Treatment of malignant melanoma by fast neutrons
Authors:
- 1 July 1985
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 72 (7) , 517-519
Abstract
Fast neutron therapy has been used to treat 87 tumours of primary, recurrent or metastatic melanoma in 48 patients. Complete regression has been obtained in 71 percent of tumours and 91 per cent of all tumours were controlled for the remainder of the patients, lives. Median survival was 14·5 months; 30 of the 34 deaths were due to metastases. Complications arose in 22 per cent of sites and were either fibrosis, which was related to large treated areas, previous surgery or a higher than standard dose, or necrosis which was related to sites with poor circulation, such as in the lower limb. It is suggested that for the treatment of advanced local disease fast neutron therapy is more effective than X-ray treatment and has a local control rate similar to that of surgery.Keywords
This publication has 17 references indexed in Scilit:
- Pigmentation and skin reaction to sun as risk factors for cutaneous melanoma: Western Canada Melanoma Study.BMJ, 1984
- The pathogenesis of cutaneous malignant melanoma.BMJ, 1983
- The Extent of Primary Melanoma ExcisionAnnals of Surgery, 1983
- How wide and deep is wide and deep enough?Human Pathology, 1983
- Patientsʼ Perceptions of the Cosmetic Impact of Melanoma ResectionPlastic and Reconstructive Surgery, 1983
- Optimal Resection Margin for Cutaneous Malignant MelanomaPlastic and Reconstructive Surgery, 1983
- Severe sunburn and subsequent risk of primary cutaneous malignant melanoma in scotlandBritish Journal of Cancer, 1982
- Radiotherapy for malignant melanoma: A re-appraisalCancer Treatment Reviews, 1981
- Tumour thickness and the site and time of first recurrence in cutaneous malignant melanoma (stage I)British Journal of Surgery, 1980
- Thickness, Cross-Sectional Areas and Depth of Invasion in the Prognosis of Cutaneous MelanomaAnnals of Surgery, 1970